Day One Biopharmaceutical Announced It Will Present New Ojemda Durability And Clinical Stability Data From The Registrational Firefly-1 Study At The 30Th Annual Meeting & Education Day Of The Society For Neuro-oncology (Sno)
Author: Benzinga Newsdesk | November 10, 2025 07:13am